Preferred Label : Basal ganglia calcification, idiopathic, 1;
Symbol : IBGC1;
CISMeF acronym : BSPDC; IBGC1; IBGC3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Fahr disease, familial; Cerebral calcification, nonarteriosclerotic, idiopathic, adult-onset; Striopallidodentate calcinosis, autosomal dominant, adult-onset; Striopallidodentate calcinosis, bilateral; Ferrocalcinosis, cerebrovascular; Basal ganglia calcification, idiopathic, 3; BSPDC; IBGC3; Primary familial brain calcification; Basal ganglia calcification, idiopathic, 2; PFBC; IBGC2; IBGC;
Description : Familial idiopathic basal ganglia calcification is an autosomal dominant condition
characterized by symmetric calcification in the basal ganglia and other brain regions.
Patients with calcifications can either be asymptomatic or show a wide spectrum of
neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia,
psychosis, seizures, and chronic headache. Serum levels of calcium, phosphate, alkaline
phosphatase, and parathyroid hormone are normal. The typical age at clinical onset
is between 30 and 50 years (summary by Wang et al., 2012). Calcification of the basal
ganglia is a nonspecific finding in many medical conditions, including infectious,
metabolic, and genetic syndromes. In addition, calcification of the basal ganglia
is observed as an incidental finding in approximately 0.7 to 1.2% of CT scans (Koller
et al., 1979; Harrington et al., 1981; Forstl et al., 1992). These incidental calcifications
are usually benign and have no clear etiology, especially in patients over 60 years
of age (Geschwind et al., 1999). Forstl et al. (1992) found no increased risk for
dementia, cerebral infarction, seizures, alcoholism, vertigo, or headache in 166 patients
with calcification of the basal ganglia compared to 622 individuals without calcification.
- Genetic Heterogeneity of Idiopathic Basal Ganglia Calcification;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the solute carrier family 20 (phosphate transporter), member
2 gene (SLC20A, 158378.0001);
Laboratory abnormalities : Normal serum calcium; Normal serum phosphorus; Normal Ellsworth-Howard test, normal urinary cAMP response to parathyroid hormone
(PTH) administration; Mildly decreased phosphaturic response to PTH administration has been reported in
some cases;
Prefixed ID : #213600;
Origin ID : 213600;
UMLS CUI : C4551624;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)